Edwards Lifesciences Corporation (NYSE:EW) Q4 2022 Earnings Call Transcript
Operator: Greetings, and welcome to the Edwards Lifesciences Fourth Quarter 2022 Earnings Conference Call. Please note, this conference is being recorded.
Edwards Lifesciences Corp (EW)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Marshall Wace LLP Paul Marshall And Ian Wace | 4,154,027 | $309,931,954 | +19% | 0.69% |
| 2. | Two Sigma Advisors John Overdeck And David Siegel | 3,503,803 | $261,418,742 | +162% | 0.72% |
| 3. | D E Shaw D. E. Shaw | 2,810,294 | $209,676,035 | +536% | 0.23% |
| 4. | Holocene Advisors Brandon Haley | 2,632,195 | $196,388,069 | -9% | 1.19% |
| 5. | Balyasny Asset Management Dmitry Balyasny | 1,135,279 | $84,703,166 | 0.23% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $112.23 | 1,500 | Director | 63,811 | 2021-11-24 | Filing | |
| $90.10 | 3,000 | Director | 9,042 | 2017-02-03 | Filing | |
| $83.33 | 3,942 | Officer | 3,942 | 2016-11-30 | Filing | |
| $83.47 | 8,928 | Officer | 43,690 | 2016-11-30 | Filing | |
| $84.63 | 3,000 | Director | 6,042 | 2016-11-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $77.47 | 4,435 | Officer | 18,911 | 2023-03-15 | Filing | |
| $77.86 | 10,700 | Officer, Director | 60,948 | 2023-03-14 | Filing | |
| $77.32 | 9,175 | Officer, Director | 81,148 | 2023-03-14 | Filing | |
| $76.95 | 6,590 | Officer | 168,875 | 2023-03-08 | Filing | |
| $77.43 | 50 | Officer | 175,465 | 2023-03-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 53,061,808 | $3,958,941,511 | 0.12% | |
| 2. | 51,559,391 | $3,846,846,162 | 0.1% | |
| 3. | 27,301,166 | $2,036,939,995 | 0.11% | |
| 4. | 22,741,986 | $1,696,855,626 | 0.45% | |
| 5. | 21,874,280 | $1,632,040,031 | 0.73% |
News See All
Multiple Reasons for the Decline of Edwards Lifesciences Corporation (EW) Stock
Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here.
Is Edwards Lifesciences (EW) a Smart Long-Term Buy?
Wedgewood Partners, an investment management firm, published its fourth quarter 2022 investor letter – a copy of which can be downloaded here.
Jim Cramer's Top 4 Recession-Proof Stock Picks
Jim Cramer last month predicted that Danaher is going to have a great year in 2023 and called the company “one of the best-run companies in any industry.” Danaher has been increasing its dividends...
5 Best Medical Technology Stocks to Buy
Edwards Lifesciences Corporation (NYSE:EW) is a California-based provider of products and technologies for structural heart disease, critical care, and surgical monitoring in the United States, Europe...
5 Biggest Medical Device Companies in the World
In this article we will take a look at the 5 biggest medical device companies in the world.
10 Best 52-Week Low Stocks To Buy Now
With a recession looming and a bear market having taken hold this year, it’s not surprising that many stocks are hovering around 52-week lows.
Should You Invest in Edwards Lifesciences Corporation (EW) Now
Wedgewood Partners, an investment management company, released its “Large Cap Focused Growth Fund” third-quarter 2022 investor letter. A copy of the same can be downloaded here.
12 Best Growth Stocks to Buy According to Ray Dalio
Ray Dalio, after a 47-year successful investment career, stepped down from his role as the co-chief investment officer of Bridgewater Associates at the end of September, and he gave up his voting rights...
12 Best Medical Technology Stocks to Buy
The medical technology industry can finally start to put the COVID-19 virus behind it after United States President Joe Biden admitted in a recent interview that the pandemic was over.
Billionaire Hedge Funds
